UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2013-12, Vol.72 (12), p.1905-1913

2013

Volltextzugriff (PDF)

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Volltextzugriff (PDF)

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

Lupus, 2010-10, Vol.19 (11), p.1281-1289

2010

Volltextzugriff (PDF)

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1155-1157

2010

Volltextzugriff (PDF)

Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project

Osteoarthritis and cartilage, 2018-08, Vol.26 (8), p.1078-1086

2018

Volltextzugriff (PDF)

Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria

Scientific reports, 2019-07, Vol.9 (1), p.10024-9, Article 10024

2019

Volltextzugriff (PDF)

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

Annals of the Rheumatic Diseases, 2010-11, Vol.69 (11), p.1913-1919

2010

Volltextzugriff (PDF)

AB0706 Observation Study of Patients with Scleroderma in Slovak Population., Including Capillaroscopy – Method for Searching Patient with Early Stage of Scleroderma in Patients with Raynauld Syndrome

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1134-1134

2015

Volltextzugriff (PDF)

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria

Molecular genetics and metabolism reports, 2022-03, Vol.30, p.100846-100846, Article 100846

2022

Volltextzugriff (PDF)

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1015-1021

2010

Volltextzugriff (PDF)

Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A

Lupus, 2014-01, Vol.23 (1), p.69-74

2014

Volltextzugriff (PDF)

AB0669 Incidence of Acute Anterior Uveitis in Patients with Ankylosing Spondylitis during Anti-TNF Therapy in Slovakia

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1026-1026

2014

Volltextzugriff (PDF)

THU0216 Adherence to Anti-TNF Therapy in Patients with Ankylosing Spondylitis – Results from Daily Clinical Practice in Slovakia

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.274-274

2015

Volltextzugriff (PDF)

AB0415 Four Years of Experience with Quantiferon-TB Gold Test in Patients with Biological Treatment

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1032-1033

2015

Volltextzugriff (PDF)

THU0217 Paradoxical Psoriatic Effects of Anti-TNF Therapy in Patients with Ankylosing Spondylitis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.274-275

2015

Volltextzugriff (PDF)

SAT0441 Effect of Choline-Stabilized Orthosilicic Acid on Symptoms of Knee Osteoarthritis in A Randomized, Double-Blind, Placebo-Controlled Trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.753-754

2014

Volltextzugriff (PDF)

AB0489 Pulse Cyclophosphamide Therapy of Lupus-Nephritis and Its Course through the Maintenance Therapy

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.969-969

2014

Volltextzugriff (PDF)

FRI0158 The conversion of quantiferon TB gold test during biological treatment by anti-TNF preparations

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.364-365

2013

Volltextzugriff (PDF)

AB0428 Study on the Efficacy and Safety of Tocilizumab in Patients with Rheumatoid Arthritis in Slovakia: One Year Results of Prospective, Open Label Study Close to Clinical Practice

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.948-949

2014

Volltextzugriff (PDF)

Asherson's syndrome — Catastrophic antiphospholipid syndrome

Autoimmunity reviews, 2006-12, Vol.6 (2), p.61-63

Rovensky, J

2006

Volltextzugriff (PDF)

Genetics of neuroendocrine factors in rheumatoid arthritis

Hormone and metabolic research, 2015-06, Vol.47 (6), p.411-417

2015

Volltextzugriff (PDF)

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1490-1493

2005

Volltextzugriff (PDF)

Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment

JIMD Reports, Volume 41, 2018-01, Vol.41, p.1-10

2018

Volltextzugriff (PDF)

THU0479 Dheas-Associated Genotypes Contribute to Adrenal Androgen Hypofunction in RA

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.349-349

2014

Volltextzugriff (PDF)

FRI0414 The risk of tuberculosis in patients with ankylosing spondylitis during anti-tnf therapy: data from national database in slovakia

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A513-A514

2013

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(186)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(288)
Science & Technology
(173)
Life Sciences & Biomedicine
(162)
Female
(155)
Male
(154)
Adult
(114)
Middle Aged
(101)
Rheumatology
(75)
Animals
(67)
Biological And Medical Sciences
(59)
Aged
(55)
Medical Sciences
(51)
Child
(40)
Adolescent
(37)
Rats
(29)
Lupus Erythematosus, Systemic - Immunology
(28)
Old Medline
(26)
Mice
(25)
Cell Biology
(24)
Diseases Of The Osteoarticular System
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project

Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

AB0706 Observation Study of Patients with Scleroderma in Slovak Population., Including Capillaroscopy – Method for Searching Patient with Early Stage of Scleroderma in Patients with Raynauld Syndrome

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A

AB0669 Incidence of Acute Anterior Uveitis in Patients with Ankylosing Spondylitis during Anti-TNF Therapy in Slovakia

THU0216 Adherence to Anti-TNF Therapy in Patients with Ankylosing Spondylitis – Results from Daily Clinical Practice in Slovakia

AB0415 Four Years of Experience with Quantiferon-TB Gold Test in Patients with Biological Treatment

THU0217 Paradoxical Psoriatic Effects of Anti-TNF Therapy in Patients with Ankylosing Spondylitis

SAT0441 Effect of Choline-Stabilized Orthosilicic Acid on Symptoms of Knee Osteoarthritis in A Randomized, Double-Blind, Placebo-Controlled Trial

AB0489 Pulse Cyclophosphamide Therapy of Lupus-Nephritis and Its Course through the Maintenance Therapy

FRI0158 The conversion of quantiferon TB gold test during biological treatment by anti-TNF preparations

AB0428 Study on the Efficacy and Safety of Tocilizumab in Patients with Rheumatoid Arthritis in Slovakia: One Year Results of Prospective, Open Label Study Close to Clinical Practice

Asherson's syndrome — Catastrophic antiphospholipid syndrome

Genetics of neuroendocrine factors in rheumatoid arthritis

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment

THU0479 Dheas-Associated Genotypes Contribute to Adrenal Androgen Hypofunction in RA

FRI0414 The risk of tuberculosis in patients with ankylosing spondylitis during anti-tnf therapy: data from national database in slovakia

Suchergebnisse filtern